Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.

Dr. Saiman is from the Department of Pediatrics, Columbia University, New York, New York. Dr. Siegel is from the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas. Address reprint requests to Cystic Fibrosis Foundation, 6931 Arlington Road, Bethesda, MD 20814; telephone: (800) FIGHT-CF; website: www.info@cff.org. The authors thank Sherrie Myers and Elizabeth Garber for their assistance in the preparation of this document. This material is being published simultaneously in Infection Control and Hospital Epidemiology and the American Journal of Infection Control. Copyright SLACK Incorporated. INFECTION CONTROL RECOMMENDATIONS FOR PATIENTS WITH CYSTIC FIBROSIS: MICROBIOLOGY, IMPORTANT PATHOGENS, AND INFECTION CONTROL PRACTICES TO PREVENT PATIENT-TO-PATIENT TRANSMISSION